AU8219191A - Stable aqueous drug suspensions - Google Patents

Stable aqueous drug suspensions

Info

Publication number
AU8219191A
AU8219191A AU82191/91A AU8219191A AU8219191A AU 8219191 A AU8219191 A AU 8219191A AU 82191/91 A AU82191/91 A AU 82191/91A AU 8219191 A AU8219191 A AU 8219191A AU 8219191 A AU8219191 A AU 8219191A
Authority
AU
Australia
Prior art keywords
stable aqueous
aqueous drug
drug suspensions
suspensions
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU82191/91A
Inventor
Milton Robert Kaplan
Catherine Sue Lamb
Chel Wing Lew
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KALMO ENTERPRISES Inc
Original Assignee
KALMO ENTERPRISES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KALMO ENTERPRISES Inc filed Critical KALMO ENTERPRISES Inc
Publication of AU8219191A publication Critical patent/AU8219191A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
AU82191/91A 1990-06-14 1991-06-13 Stable aqueous drug suspensions Abandoned AU8219191A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53818390A 1990-06-14 1990-06-14
US538183 1990-06-14

Publications (1)

Publication Number Publication Date
AU8219191A true AU8219191A (en) 1992-01-07

Family

ID=24145861

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82191/91A Abandoned AU8219191A (en) 1990-06-14 1991-06-13 Stable aqueous drug suspensions

Country Status (4)

Country Link
AU (1) AU8219191A (en)
CA (1) CA2085342A1 (en)
IL (1) IL98508A0 (en)
WO (1) WO1991019486A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
SE9201930D0 (en) * 1992-06-24 1992-06-24 Astra Ab GASTRIC ANTIBACTERIAL TREATMENT
AT403988B (en) * 1994-05-18 1998-07-27 Lannacher Heilmittel SOLID ORAL RETARDED PREPARATION
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
AU719137B2 (en) * 1996-05-07 2000-05-04 Mayne Pharma International Pty Ltd Taste masked liquid suspensions
DE19648576C2 (en) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lozenge for modified release of active substances in the gastrointestinal tract
DE19706979A1 (en) * 1997-02-21 1998-08-27 Lindopharm Gmbh Combination preparation for oral erythromycins
US6197331B1 (en) 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
DE19741114C2 (en) * 1997-09-12 2002-10-24 Riemser Arzneimittel Ag Moisture-stable and enteric drug form for fish
US6500461B2 (en) 1998-05-20 2002-12-31 The Liposome Company Particulate formulations
SI20244A (en) * 1999-05-19 2000-12-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Melt granulation
JP2004528272A (en) * 2000-10-13 2004-09-16 アドバンシス ファーマスーティカルス Extended release erythromycin derivatives
JP2004529953A (en) * 2001-05-11 2004-09-30 エラン コーポレーシヨン ピーエルシー Isostearate as a penetration enhancer
US20030124196A1 (en) 2001-08-22 2003-07-03 Susan Weinbach Pulsatile release compositions and methods for enhanced intestinal drug absorption
CA2480824A1 (en) 2002-04-09 2003-10-16 Flamel Technologies Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
PT1492511E (en) 2002-04-09 2009-04-09 Flamel Tech Sa Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
FR2843880B1 (en) * 2002-09-02 2006-06-02 Flamel Tech Sa ORAL PHARMACEUTICAL FORMULATION AS AQUEOUS SUSPENSION OF MICROCAPSULES FOR MODIFIED AMOXICILLIN RELEASE
DE10260921A1 (en) * 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Process for coating substrates for pharmaceutical applications with a mixture of two film-forming coating agents
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
GB2569119A (en) * 2017-12-05 2019-06-12 Rainbow Valley Nutrients Ltd An aqueous beverage containing microencapsulated food supplement

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250166A (en) * 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
JPS601128A (en) * 1983-06-15 1985-01-07 Shionogi & Co Ltd Long-acting cefaclor preparation
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions

Also Published As

Publication number Publication date
IL98508A0 (en) 1992-07-15
WO1991019486A1 (en) 1991-12-26
CA2085342A1 (en) 1991-12-15

Similar Documents

Publication Publication Date Title
AU656157B2 (en) Pharmaceutical agents
AU672579B2 (en) Stable aqueous suspension of liposome
AU653734B2 (en) Substituted 4-biphenylmethoxypyridine derivatives
AU8219191A (en) Stable aqueous drug suspensions
AU644249B2 (en) Alpha-oxoacetamide derivatives
AU1802492A (en) New aqueous formulations
AU638496B2 (en) Acyl-biphenylyl-alkyl pyrimidine derivatives
AU7707591A (en) Hydroquinazoline derivatives
AU7500891A (en) Benzimidazolinone derivatives
AU6860691A (en) Azaoxindole derivatives
AU634039B2 (en) Hydantoin derivatives
AU641748B2 (en) Electro-magnetic desensitizer
AU9049391A (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity
AU8033891A (en) Pyrimidine derivatives
AU7825291A (en) Pyridinypiperazine derivatives
AU6314890A (en) Novel cephalosporin derivatives
AU6245690A (en) Guanidine derivatives
AU7874291A (en) Packaging-material body
AU8531891A (en) Imidazoline derivatives
AU5533594A (en) Stable aqueous liposome suspension
AU8994791A (en) Cephalosporin derivatives
AU7949691A (en) 5-isothiazolamine derivatives
AU1431895A (en) Stable aqueous dipeptide suspensions
AU7083491A (en) Pyrimidin-2-ylphenylhydroxylamine derivatives
AU8138991A (en) Carboxymethylcyclopropane derivatives